Joseph Saad
8PUBLICATIONS
80CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 14, 2026
Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy.Ida Vänttinen, Joseph Saad, Tanja Ruokoranta
|Sep 21, 2025
Predictors of response and rational combinations for the novel MCL-1 inhibitor MIK665 in acute myeloid leukemia.Joseph Saad, Rhiannon Newman, Elmira Khabusheva
|Apr 09, 2025
DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes.Fadimana Kaya, Findlay Bewicke-Copley, Juho J Miettinen
|Oct 02, 2024
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial.Sari Kytölä, Ida Vänttinen, Tanja Ruokoranta
|Jan 10, 2024
Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia.Samuli Eldfors, Joseph Saad, Nemo Ikonen
|Dec 12, 2022
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela
Pageof 2
Frequent Collaborators
8 joint publications
Caroline A Heckmann
4 joint publications
Mika Kontro
3 joint publications
Kimmo Porkka
3 joint publications
Heikki Kuusanmäki
2 joint publications
Juho Miettinen
2 joint publications
Samuli Eldfors
2 joint publications
Tanja Ruokoranta
2 joint publications
Markus Vähä-Koskela
2 joint publications
Ida Vänttinen
1 joint publications
Vésteinn Thorsson
